stocksINDGN
496.00+4.1 (+0.84%)
8 Jul, 12:00 AM

Income Statement

Abridged
Understanding Income Statement
Indegene Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PR
12M
AR
12M
AR
12M
PRESS
Total Revenue
6439661,6652,3062,5902,8393,511
Gross Profit
6439661,6652,3062,5902,8393,511
Gross Margin
100.0100.0100.0100.0100.0100.0100.0
Total Operating Expenses
5197611,4111,9702,1552,3853,018
Operating Profit
124205253336435454493
Operating Margin
19.321.215.214.616.816.014.0
Financing Income/(Expense) - Net
-6-331419-438-19
Profit before Taxes
76231226363459539525
Income Taxes
26466497122133124
Profit after Tax
-6149165266337407401
PAT Margin
-1.015.59.911.513.014.311.4
EPS - Basic - ex Extraordinary Items
2.337.766.8911.1215.1917.1516.72
EPS - Diluted - ex Extraordinary Items
2.337.766.8911.1215.1917.1516.62
EBIT
124205253336435454493
EBITDA
157240287396511535619
EBITDA Margin
24.524.817.217.219.718.817.6

Balance Sheet

Abridged
Understanding Balance Sheet
Indegene Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
PR
PR
PR
PR
AR
AR
PRESS
Total Current Assets
4184591,1301,4491,7912,5302,618
Long-Term Investments
13-----80
Property Plant & Equipment - Net
404680146114139206
Total Non-Current Assets
1831372237557557962,002
Total Assets
6005961,3532,2042,5463,3264,620
Total Current Liabilities
2471994404896115651,086
Long Term Debt
360314448039972105
Total Non-Current Liabilities
36964149651506146395
Total Liabilities
6162635901,1401,1177101,482
Total Shareholders' Equity
-1053257641,0641,4292,6163,139
Minority Interest
899-----
Total Equity
-163337641,0641,4292,6163,139
Total Liabilities & Equity
6005961,3532,2042,5463,3264,620

Cash Flow

Abridged
Understanding Cash Flow Statement
Indegene Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PR
12M
AR
12M
AR
12M
PRESS
Operating CF bef Changes in Working Cap
78161241335406456517
Working Capital - Increase/(Decrease)
-59954-2169624146
Net CF from Operating Activities
19169295119502480663
Capital Expenditures - Net
6212519113044
Net CF from Investing Activities
-19-25-161-900-353-731-525
Dividends Paid - Cash - Total
------48
Stock - Issuance/(Retirement) - Net
0-22620-7335
Debt - LT & ST - Issuance/(Retirement) - Total
45-126-23351-35-435-40
Net Cash Flow from Financing Activities
140-128236351-35298-83
Free Cash Flow to Equity
582224745145715579
Free Operating CF net dividend
13149270100492450571
Free Operating CF
13149270100492450619

Business Segment Analysis

FY End:
Mar 25

Indegene Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales
Total₹ 3,187Cr
Enterprise Commercial Solutions (49.8%)₹ 1,587.10 CrEnterprise Medical Solutions (25.2%)₹ 802.50 CrBrand Activation (10.9%)₹ 347.70 CrOmnichannel Activation (10.9%)₹ 347.70 CrOthers (3.2%)₹ 102.00 Cr
Operating Income
Total₹ 681Cr
Enterprise Commercial Solutions (51.2%)₹ 348.40 CrEnterprise Medical Solutions (30.6%)₹ 208.10 CrBrand Activation (6.7%)₹ 45.80 CrOmnichannel Activation (6.7%)₹ 45.80 CrOthers (4.8%)₹ -32.90 Cr

Regional Segment Analysis

FY End:
Mar 25

Indegene Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales
Total₹ 2,839Cr
North America (70.1%)₹ 1,991.40 CrEurope (26.8%)₹ 761.00 CrRest of the world (2.4%)₹ 67.50 CrIndia (0.7%)₹ 19.40 Cr

Historical Segment Analysis

Track how Indegene Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Business
We don't have enough data to show the Capex for Indegene Ltd..

Frequently Asked Questions

What is the revenue of Indegene Ltd.?
The latest trailing twelve month revenue of Indegene Ltd. is ₹ 3,510.50 Cr, reflecting a 1-year growth of 23.64% and a 3-year CAGR of 15.03%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Indegene Ltd.?
The latest trailing twelve month net profit (PAT) of Indegene Ltd. is ₹ 401.10 Cr, with a 3-year earnings CAGR of 14.33%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Indegene Ltd.?
The trailing twelve month EBITDA of Indegene Ltd. is approximately ₹ 492.60 Cr (based on an operating margin of 14.03%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Indegene Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Indegene Ltd. is 16.62. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Indegene Ltd.?
The debt-to-equity ratio of Indegene Ltd. stands at 0.05. The interest coverage ratio is 25.52x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Indegene Ltd.?
The estimated book value per share of Indegene Ltd. is 130.74 (derived from a P/B ratio of 3.79 and market price of ₹ 496.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Indegene Ltd.?
The trailing twelve month operating cash flow of Indegene Ltd. is ₹ 663.40 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Indegene Ltd. report consolidated or standalone financials?
Indegene Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.